secwatch.observer — SEC 8-K summary
======================================

Issuer:     Armata Pharmaceuticals, Inc. (ARMP)
CIK:        0000921114
Form:       8-K
Filed at:   2026-01-26T23:59:59+00:00
Accession:  0001104659-26-006446
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Armata extends credit maturity to June 2027 and warrants to Jan 2031 with Innoviva affiliate
--------------------------------------------------------------------------------

- Maturity of four credit agreements with Innoviva Sub extended to June 1, 2027.
- Expiration of four warrants to purchase ~10.65M shares extended to January 26, 2031.
- Voting agreement termination date extended to earlier of Jan 2031 or FDA approval of any product candidate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921114/000110465926006446/0001104659-26-006446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921114/000110465926006446/tm263967d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-006446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer